FINWIRES · TerminalLIVE
FINWIRES

摩根士丹利表示,花旗集团第一季度业绩强劲,有望在投资者日上公布“15%左右”的回报率预期。

-- 摩根士丹利周三发布的一份报告称,花旗集团(C)在公布第一季度各项指标均超出预期后,有望在5月7日的投资者日上阐述其有形普通股回报率达到“15%左右”的路径。 该投资银行将花旗集团的目标股价从140美元上调至144美元,重申了“增持”评级和“首选股”地位。报告指出,花旗集团第一季度“有形普通股回报率(ROTCE)”持续改善,且资本回报好于预期,其中包括63亿美元的股票回购,而预期为44亿美元。 “费用率和股票回购”仍然是进一步提升回报率的关键因素。花旗集团第一季度的费用率为58%,低于市场普遍预期的61%。该投资银行预测,随着转型项目完成度达到90%(高于上季度的80%),花旗集团的费用率将继续下降,到2030年将降至56.4%。 花旗集团排除了收购“区域性银行”的可能性,并继续专注于“内生增长”。其核心业务(包括服务、市场、银行和财富管理)的强劲表现支撑了更高的回报预期。 分析师补充道,鉴于花旗集团将在投资者日上进一步阐明其实现15%左右ROTCE(有形权益回报率)的战略,目前估值尚未充分反映这一潜力,因此其股价可能进一步上涨。

Price: $131.47, Change: $+1.89, Percent Change: +1.46%

Related Articles

Asia

Update: Origin Energy Reports Lower March Quarter Production; Shares Fall 3%

(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.

$ASX:ORG
Asia

Alterity Therapeutics Secures US FDA Support for ATH434 Phase Three Program

Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.

$ASX:ATH
Asia

Xinyuan Property Management's CFO Resigns

Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.

$HKG:1895